These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 3711960)

  • 61. Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
    Canellos GP; Anderson JR; Propert KJ; Nissen N; Cooper MR; Henderson ES; Green MR; Gottlieb A; Peterson BA
    N Engl J Med; 1992 Nov; 327(21):1478-84. PubMed ID: 1383821
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Secondary malignancy after treatment of Hodgkin's disease: an evolving picture.
    Coleman CN
    J Clin Oncol; 1986 Jun; 4(6):821-4. PubMed ID: 3711957
    [No Abstract]   [Full Text] [Related]  

  • 63. Secondary leukemia following treatment of Hodgkin's disease: ultrastructural and cytogenetic data in two cases with a review of the literature.
    Yahalom J; Voss R; Leizerowitz R; Fuks Z; Polliack A
    Am J Clin Pathol; 1983 Aug; 80(2):231-6. PubMed ID: 6349327
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bone and soft tissue sarcomas in the follow-up of Hodgkin's disease.
    Zanini M; Zucali R; Banfi A
    Tumori; 1983 Oct; 69(5):473-6. PubMed ID: 6196892
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Acute nonlymphocytic leukemia: a delayed complication of Hodgkin's disease therapy: analysis of 109 cases.
    Cadman EC; Capizzi RL; Bertino JR
    Cancer; 1977 Sep; 40(3):1280-96. PubMed ID: 409479
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.
    Mauch PM; Kalish LA; Marcus KC; Coleman CN; Shulman LN; Krill E; Come S; Silver B; Canellos GP; Tarbell NJ
    Blood; 1996 May; 87(9):3625-32. PubMed ID: 8611686
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Second malignancies in Hodgkin's disease: a complication of certain forms of treatment.
    Valagussa P; Santoro A; Kenda R; Fossati Bellani F; Franchi F; Banfi A; Rilke F; Bonadonna G
    Br Med J; 1980 Jan; 280(6209):216-9. PubMed ID: 6775732
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The impact of stage and treatment modality on the likelihood of second malignancies and hematopoietic disorders in Hodgkin's disease.
    Mendenhall NP; Shuster JJ; Million RR
    Radiother Oncol; 1989 Mar; 14(3):219-29. PubMed ID: 2710953
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact on second malignancy risk of the combined use of radiation and chemotherapy for lymphomas.
    Lavey RS; Eby NL; Prosnitz LR
    Cancer; 1990 Jul; 66(1):80-8. PubMed ID: 2354413
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?
    Dietrich PY; Henry-Amar M; Cosset JM; Bodis S; Bosq J; Hayat M
    Blood; 1994 Aug; 84(4):1209-15. PubMed ID: 8049435
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Acute leukaemia in patients treated for Hodgkin's disease.
    Papa G; Mauro FR; Anselmo AP; Cimino G; Alimena G; Amadori S; D'Arcangelo E; Giannarelli D; Bosi A; Bellesi G
    Br J Haematol; 1984 Sep; 58(1):43-52. PubMed ID: 6466571
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.
    van Leeuwen FE; Chorus AM; van den Belt-Dusebout AW; Hagenbeek A; Noyon R; van Kerkhoff EH; Pinedo HM; Somers R
    J Clin Oncol; 1994 May; 12(5):1063-73. PubMed ID: 8164031
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Breast cancer after treatment of Hodgkin's disease.
    Hancock SL; Tucker MA; Hoppe RT
    J Natl Cancer Inst; 1993 Jan; 85(1):25-31. PubMed ID: 8416252
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease.
    van Leeuwen FE; Somers R; Taal BG; van Heerde P; Coster B; Dozeman T; Huisman SJ; Hart AA
    J Clin Oncol; 1989 Aug; 7(8):1046-58. PubMed ID: 2754447
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Non-Hodgkin's lymphoma occurring after Hodgkin's disease. Four new cases and a review of the literature.
    Jacquillat C; Khayat D; Desprez-Curely JP; Weil M; Brocheriou C; Auclerc G; Chamseddine N; Bernard J
    Cancer; 1984 Feb; 53(3):459-62. PubMed ID: 6362816
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
    Pedersen-Bjergaard J; Ersbøll J; Sørensen HM; Keiding N; Larsen SO; Philip P; Larsen MS; Schultz H; Nissen NI
    Ann Intern Med; 1985 Aug; 103(2):195-200. PubMed ID: 4014901
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Risk of leukemia following treatment for non-Hodgkin's lymphoma.
    Travis LB; Curtis RE; Stovall M; Holowaty EJ; van Leeuwen FE; Glimelius B; Lynch CF; Hagenbeek A; Li CY; Banks PM
    J Natl Cancer Inst; 1994 Oct; 86(19):1450-7. PubMed ID: 8089863
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hodgkin's disease and acute leukemia. Report of eight cases and review of the literature.
    Rosner F; Grünwald H
    Am J Med; 1975 Mar; 58(3):339-53. PubMed ID: 1090158
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Second solid malignancies after combined modality therapy for Hodgkin's disease.
    Doria R; Holford T; Farber LR; Prosnitz LR; Cooper DL
    J Clin Oncol; 1995 Aug; 13(8):2016-22. PubMed ID: 7636543
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Leukemia following low-dose total body irradiation and chemotherapy for non-Hodgkin's lymphoma.
    Travis LB; Weeks J; Curtis RE; Chaffey JT; Stovall M; Banks PM; Boice JD
    J Clin Oncol; 1996 Feb; 14(2):565-71. PubMed ID: 8636772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.